Attached files
| file | filename |
|---|---|
| 10-K - Pathfinder Cell Therapy, Inc. | v178047_10k.htm |
| EX-31.1 - Pathfinder Cell Therapy, Inc. | v178047_ex31-1.htm |
| EX-23.1 - Pathfinder Cell Therapy, Inc. | v178047_ex23-1.htm |
| EX-10.11 - Pathfinder Cell Therapy, Inc. | v178047_ex10-11.htm |
EXHIBIT
32.1: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL
OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.
In
connection with the accompanying Annual Report on Form 10-K of SyntheMed, Inc.
for the fiscal year ended December 31, 2009, the undersigned hereby certifies
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief,
that:
(1) such
Annual Report on Form 10-K for the fiscal year ended December 31, 2009 fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
(2) the
information contained in such Annual Report on Form10-K for the fiscal year
ended December 31, 2009 fairly presents, in all material respects, the financial
condition and results of operations of SyntheMed, Inc.
|
March
22, 2010
|
/s/ Robert P. Hickey
|
|
|
Name:
Robert P. Hickey
|
||
|
Title:
President, CEO and CFO
|